TNFSF10 and diabetes mellitus: Future research in humans should address the course of circulating soluble TRAIL levels in diabetic patients at different stages of the disease and in the presence of different diabetes-related comorbidities, and explore the impact of glycemic control and antidiabetic treatment on TRAIL alterations.